BD uses Carbon’s 3D tech to mold intricate part

Becton Dickinson has begun using Carbon’s 3D printing technology to manufacture its hemocytometer adapter.

Becton, Dickinson and Company (BD) has begun producing parts based on Carbon’s digital light synthesis technology, including BD’s first production part using additive manufacturing — a hemocytometer adapter for the company’s Rhapsody single-cell genomic analysis system.

This component would have been impractical and expensive to injection mold, according to Redwood City, Calif.–based Carbon, which said it offered BD a cost-effective solution to address difficult-to-mold geometries without sacrificing part quality.

BD had identified products struggling with part geometries or economies of scale with both injection molding and milling and began a program to examine additive processes, materials, and companies claiming to meet demanding medical applications. Carbon produced a case study examining how BD identified the application for additive manufacturing and why it selected Carbon and its MPU 100 medical-grade material for production. MPU 100 is Carbon’s first material designed to help medical product manufacturers accelerate product development cycles and improve the quality of their products. Similar to Carbon’s rigid polyurethane materials, MPU 100 is a two-component material that produces isotropic parts with fine features.

Get the full story on our sister site, Medical Design & Outsourcing.

 

The post BD uses Carbon’s 3D tech to mold intricate part appeared first on MassDevice.

from MassDevice https://ift.tt/2OhiFJw